TMO logo

Thermo Fisher Scientific (TMO)

Profile

Full Name

Thermo Fisher Scientific Inc.

Ticker Symbol

TMO

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.thermofisher.com

Employees

125000

Key Details

Price

$423.55(+0.87%)

Market cap

$159.89B(Mega cap)

Last Dividend

$0.43

TTM Dividend yield

0.38%

Annual revenue

$42.88B(+0.05% YoY)

Annual EPS

$16.53(+6.99% YoY)

PE ratio

24.84

Next earnings date

Jul 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$423.55
TMO price is $423.55

30-Day Relative Volume

0.93
TMO 30-day relative volume is 0.93

Price Performance

Price Most recent change

+0.87%
TMO price was up +0.87% on May 2, 2025

Price YTD change

-18.58%
TMO price is down -18.58% since January 1st

Price 1-year change

-25.86%
TMO price is down -25.86% year-on-year

Price 3-year change

-22.36%
TMO price is down -22.36% over the past 3 years

Price Range

Price All-time high

$672.34
TMO price is currently -37.00% below its historical high of $672.34

Price 3-year low

$409.85
TMO price is currently +3.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$159.89B
TMO market capitalization is $159.89 billion

Market cap 3-year change

-25.13%
TMO market capitalization is down -25.13% over the past 3 years

Market cap All-time high

$263.18B
TMO market capitalization is currently -39.25% below its historical high of $263.18 billion

Market cap sector rank

99.19%
TMO market capitalization is higher than 99.19% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.11%
TMO shares outstanding is down -1.11% year-on-year

Shares Outstanding 3-Year Change

-3.57%
TMO shares outstanding is down -3.57% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.67
TMO beta is 0.67

200-day SMA

$548.46
TMO price is currently -22.77% below its 200-day simple moving average

50-day SMA

$482.52
TMO price is currently -12.22% below its 50-day simple moving average

RSI

37.66
TMO 14-day relative strength index is 37.66

Volume

0.93
TMO 30-day relative volume is 0.93

ATR

$15.18
TMO average true range is $15.18

10-day Historical Volatility

24.32%
TMO 10-day historical volatility is 24.32%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.43
TMO last dividend was $0.43 per share, with an ex-dividend date of March 14, 2025

Next Dividend

-
TMO next dividend has not yet been announced

Dividend per share

Dividend per share

$1.56
TMO annual dividend per share is $1.56

Dividend per share Sector Rank

59.77%
TMO annual dividend per share is higher than 59.77% of companies in Healthcare sector

Dividend per share 1-Year Change

+11.43%
TMO annual dividend per share is up +11.43% year-on-year

Dividend per share 3-Year Change

+50%
TMO annual dividend per share is up +50% over the past 3 years

Dividend yield

Dividend yield

0.37%
TMO annual dividend yield is 0.37%

Dividend yield Sector Rank

9.3%
TMO annual dividend yield is higher than 9.3% of companies in Healthcare sector

Other

Payout ratio

9.20%
TMO annual payout ratio is 9.20%

Dividends paid

$583.00M
TMO annual dividends paid is $583.00 million

Free cash flow

$7.27B
TMO annual free cash flow is $7.27 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$42.88B
TMO annual revenue is $42.88 billion

Revenue Analysts estimate

$43.68B
TMO annual revenue is currently -1.84% lower than the consensus analysts' forecast

Revenue 1-year change

+0.05%
TMO annual revenue is up +0.05% year-on-year

Revenue Sector rank

97.75%
TMO annual revenue is higher than 97.75% of companies in Healthcare sector

EPS

EPS

$16.53
TMO annual earnings per share is $16.53

EPS Analysts estimate

$22.47
TMO annual earnings per share is currently -26.44% lower than the consensus analysts' forecast

EPS 1-year change

+6.99%
TMO annual earnings per share is up +6.99% year-on-year

EPS Sector rank

99.01%
TMO annual earnings per share is higher than 99.01% of companies in Healthcare sector

Profit

Gross profit

$18.06B
TMO annual gross profit is $18.06 billion

Gross margin

42.12%
TMO annual gross profit margin is 42.12%

Operating profit

$7.72B
TMO annual operating income is $7.72 billion

Operating margin

17.99%
TMO annual operating profit margin is 17.99%

Net income

$6.33B
TMO annual net profit is $6.33 billion

Net margin

14.77%
TMO annual net profit margin is 14.77%

Expenses

Total expenses

$35.16B
TMO annual total expenses is $35.16 billion

Operating expenses

$10.35B
TMO annual total operating expenses is $10.35 billion

Cost of goods sold

$24.82B
TMO annual cost of goods sold is $24.82 billion

Selling, general & administrative expenses

$7.00B
TMO annual SGA is $7.00 billion

Depreciation and amortization

$3.11B
TMO annual depreciation & amortization is $3.11 billion

Interest expense

$1.39B
TMO annual interest expense is $1.39 billion

Income tax

$657.00M
TMO annual income tax is $657.00 million

EBIT & EBITDA

EBIT

$8.43B
TMO annual earnings before interest & taxes is $8.43 billion

EBITDA

$11.54B
TMO annual EBITDA is $11.54 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$97.32B
TMO annual total assets is $97.32 billion

Non current assets

$75.18B
TMO annual long term assets is $75.18 billion

Current assets

$22.14B
TMO annual total current assets is $22.14 billion

Cash and cash equivalents

$4.01B
TMO annual cash & cash equivalents is $4.01 billion

Accounts receivable

$8.19B
TMO annual accounts receivable is $8.19 billion

Inventory

$4.98B
TMO annual inventory is $4.98 billion

Liabilities

Total liabilities

$47.65B
TMO annual total liabilities is $47.65 billion

Long term liabilities

$34.32B
TMO annual total long term liabilities is $34.32 billion

Current liabilities

$13.33B
TMO annual total current liabilities is $13.33 billion

Accounts payable

$3.08B
TMO annual accounts payable is $3.08 billion

Debt

Total debt

$31.27B
TMO annual total debt is $31.27 billion

Total debt 1-year change

-10.43%
TMO annual total debt is down -10.43% year-on-year

Long term debt

$29.06B
TMO annual long term debt is $29.06 billion

Short term debt

$2.21B
TMO annual short term debt is $2.21 billion

Equity & Capital

Shareholders equity

$49.59B
TMO annual stockholders equity is $49.59 billion

Book value

$49.55B
TMO annual book value is $49.55 billion

Retained earnings

$53.10B
TMO annual retained earnings is $53.10 billion

Working capital

$8.80B
TMO annual working capital is $8.80 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$8.67B
TMO annual cash flow from operations is $8.67 billion

Cash from operations 1-year change

+3.1%
TMO annual cash flow from operations is up +3.1% year-on-year

Cash from investing

-$5.84B
TMO annual cash flow from investing activities is -$5.84 billion

Cash from investing 1-year change

-13.59%
TMO annual cash flow from investing activities is down -13.59% year-on-year

Cash from financing

-$6.79B
TMO annual cash flow from financing activities is -$6.79 billion

Cash from financing 1-year change

-87.52%
TMO annual cash flow from financing activities is down -87.52% year-on-year

CAPEX

CAPEX

$1.40B
TMO annual capital expenditures is $1.40 billion

CAPEX 1-year change

-5.34%
TMO annual capital expenditures is down -5.34% year-on-year

Free Cash Flow

Free cash flow

$7.27B
TMO annual free cash flow is $7.27 billion

Free cash flow 1-year change

+4.91%
TMO annual free cash flow is up +4.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

42.12%
TMO annual gross profit margin is 42.12%

Operating margin

17.99%
TMO annual operating profit margin is 17.99%

Net margin

14.77%
TMO annual net profit margin is 14.77%

ROA & ROE

ROA

6.46%
TMO annual return on assets is 6.46%

ROE

13.13%
TMO annual return on equity is 13.13%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

24.84
TMO price to earnings ratio is 24.84

PE ratio Sector rank

49.27%
TMO price to earnings ratio is higher than 49.27% of companies in Healthcare sector

PB Ratio

PB ratio

3.24
TMO price to book ratio is 3.24

PB ratio Sector rank

71.38%
TMO price to book ratio is higher than 71.38% of companies in Healthcare sector

PS Ratio

PS ratio

3.73
TMO price to sales ratio is 3.73

PS ratio Sector rank

55.7%
TMO price to sales ratio is higher than 55.7% of companies in Healthcare sector

Enterprise value

Enterprise value

$189.94B
TMO enterprise value is $189.94 billion

Enterprise value Sector rank

99.42%
TMO enterprise value is higher than 99.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

16.70
TMO EV/EBITDA is 16.70

EV/EBITDA Sector rank

89.97%
TMO EV/EBITDA is higher than 89.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.66
TMO annual current ratio is 1.66

Quick ratio

1.29
TMO annual quick ratio is 1.29

Leverage

Debt to equity

0.63
TMO annual debt to equity ratio is 0.63

Interest coverage ratio

6.06
TMO annual interest coverage ratio is 6.06

Risk & Stability

Piotroski F-Score

7
TMO piotroski f-score is 7

Altman Z-Score

3.61
TMO altman z-score is 3.61

Analyst ratings

Recent major analysts updates

Apr 29, 25 Argus Research
Buy
Apr 25, 25 Scotiabank
Sector Perform
Apr 24, 25 Wells Fargo
Overweight
Apr 24, 25 UBS
Buy
Apr 24, 25 Stifel
Buy
Apr 24, 25 RBC Capital
Outperform
Apr 24, 25 Evercore ISI Group
Outperform
Apr 24, 25 Baird
Outperform
Apr 17, 25 Wells Fargo
Overweight
Apr 10, 25 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

BSX logo
Boston Scientific (BSX)
AMGN logo
Amgen (AMGN)
SYK logo
Stryker (SYK)
DHR logo
Danaher (DHR)
PFE logo
Pfizer (PFE)
SNY logo
Sanofi (SNY)
ISRG logo
Intuitive Surgical (ISRG)
GILD logo
Gilead Sciences (GILD)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
  • What is the ticker symbol for Thermo Fisher Scientific?
  • Does Thermo Fisher Scientific pay dividends?
  • What sector is Thermo Fisher Scientific in?
  • What industry is Thermo Fisher Scientific in?
  • What country is Thermo Fisher Scientific based in?
  • When did Thermo Fisher Scientific go public?
  • Is Thermo Fisher Scientific in the S&P 500?
  • Is Thermo Fisher Scientific in the NASDAQ 100?
  • Is Thermo Fisher Scientific in the Dow Jones?
  • When was Thermo Fisher Scientific's last earnings report?
  • When does Thermo Fisher Scientific report earnings?
  • Should I buy Thermo Fisher Scientific stock now?

What is the ticker symbol for Thermo Fisher Scientific?

The ticker symbol for Thermo Fisher Scientific is NYSE:TMO

Does Thermo Fisher Scientific pay dividends?

Yes, Thermo Fisher Scientific pays dividends. The last payment was $0.43, with an ex-dividend date on March 14, 2025

What sector is Thermo Fisher Scientific in?

Thermo Fisher Scientific is in the Healthcare sector

What industry is Thermo Fisher Scientific in?

Thermo Fisher Scientific is in the Diagnostics & Research industry

What country is Thermo Fisher Scientific based in?

Thermo Fisher Scientific is headquartered in United States

When did Thermo Fisher Scientific go public?

Thermo Fisher Scientific's initial public offering (IPO) was on March 17, 1980

Is Thermo Fisher Scientific in the S&P 500?

Yes, Thermo Fisher Scientific is included in the S&P 500 index

Is Thermo Fisher Scientific in the NASDAQ 100?

No, Thermo Fisher Scientific is not included in the NASDAQ 100 index

Is Thermo Fisher Scientific in the Dow Jones?

No, Thermo Fisher Scientific is not included in the Dow Jones index

When was Thermo Fisher Scientific's last earnings report?

Thermo Fisher Scientific's most recent earnings report was on Apr 23, 2025

When does Thermo Fisher Scientific report earnings?

The next expected earnings date for Thermo Fisher Scientific is Jul 24, 2025

Should I buy Thermo Fisher Scientific stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page